Bioxyne Ltd. | |
Stock Exchange | Australian Stock Exchange |
EPS |
AUD0 |
Market Cap |
AUD12.8 M |
Shares Outstanding |
640.15 M |
Public Float |
- |
Address |
50 Clarence Street Sydney New South Wales (NSW) 2000 Australia |
Employees | - |
Website | http://www.bioxyne.com |
Updated | 07/08/2019 |
Bioxyne Ltd. focuses on the development of immune health and immunotherapeutic products. It manufactures, markets, and distributes over-the-counter dietary supplement probiotic products, such as Lactobacillus Fermentum PCC. It operates through the Probiotics and Others segments. |